Single-center, non-randomized, prospective phase II study evaluating the effectiveness of induction chemoimmunotherapy in the combined outcome of locally advanced non-small cell lung disease. Voprosy onkologii, v. 71, n. 6, p. OF-2369, 30 Dec.2025.